Overview of Dr. Desai
Dr. Ankit Desai is a cardiologist in Indianapolis, IN and is affiliated with Indiana University Health University Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 14 years. He also speaks multiple languages, including English, Gujarati, Hindi, and Spanish. He specializes in adult heart disease, pulmonary vascular medicine, sickle cell disease, and cardiovascular genetics and is experienced in pulmonary hypertension, sickle-cell anemia, and medical genetics.
Office
1800 N Capitol Ave
Ste E371
Indianapolis, IN 46202- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Cardiovascular Disease, 2008 - 2010
- California Pacific Medical CenterResidency, Internal Medicine, 2003 - 2006
- University of Illinois College of MedicineClass of 2003
Certifications & Licensure
- IN State Medical License 2018 - 2025
- AZ State Medical License 2014 - 2020
- IL State Medical License 2006 - 2014
- CA State Medical License 2003 - 2006
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 23 citationseNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt/mTORC2 signaling.Tadeo Bermudez, Saad Sammani, Jin H Song, Vivian Reyes Hernon, Carrie L Kempf
Scientific Reports. 2022-01-13 - 49 citationsEndothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody.Daniel G. Valera, Jeffrey R. Jacobson, Joseph B Mascarenhas, Hector Quijada, Evelyn Franco
The European Respiratory Journal. 2021-05-01 - 22 citationsEndotoxin- and mechanical stress-induced epigenetic changes in the regulation of the nicotinamide phosphoribosyltransferase promoter.Gabriel T. Kelly, Venkateswaran Ramamoorthi Elangovan, Sara M. Camp, Ankit A. Desai, Djanybek Adyshev
Pulmonary Circulation. 2016-12-01
Press Mentions
- Beta Blocker Used to Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 5th, 2024
- Beta Blocker Used To Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 17th, 2024
Grant Support
- Sickle cell diseaseNHLBI2017–2022
Professional Memberships
- Fellow
- Fellow
- Member
- Pulmonary Hypertension AssociationScientific Leadership Council Member
- Member
- Pulmonary hypertension breakthrough initiativeMember
Other Languages
- Gujarati, Hindi, Spanish
Hospital Affiliations
- Indiana University Health University HospitalIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: